BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 22525435)

  • 1. Montmorillonite/poly-(ε-caprolactone) composites as versatile layered material: reservoirs for anticancer drug and controlled release property.
    Kevadiya BD; Thumbar RP; Rajput MM; Rajkumar S; Brambhatt H; Joshi GV; Dangi GP; Mody HM; Gadhia PK; Bajaj HC
    Eur J Pharm Sci; 2012 Aug; 47(1):265-72. PubMed ID: 22525435
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Layered inorganic nanocomposites: a promising carrier for 5-fluorouracil (5-FU).
    Kevadiya BD; Patel TA; Jhala DD; Thumbar RP; Brahmbhatt H; Pandya MP; Rajkumar S; Jena PK; Joshi GV; Gadhia PK; Tripathi CB; Bajaj HC
    Eur J Pharm Biopharm; 2012 May; 81(1):91-101. PubMed ID: 22269936
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of clay/poly (L-lactide) microcomposites as anticancer drug, 6-mercaptopurine reservoir through in vitro cytotoxicity, oxidative stress markers and in vivo pharmacokinetics.
    Kevadiya BD; Chettiar SS; Rajkumar S; Bajaj HC; Gosai KA; Brahmbhatt H
    Colloids Surf B Biointerfaces; 2013 Dec; 112():400-7. PubMed ID: 24036475
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tamoxifen-loaded nanoparticles based on a novel mixture of biodegradable polyesters: characterization and in vitro evaluation as sustained release systems.
    Pérez E; Benito M; Teijón C; Olmo R; Teijón JM; Blanco MD
    J Microencapsul; 2012; 29(4):309-22. PubMed ID: 22251238
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Montmorillonite as a drug delivery system: intercalation and in vitro release of timolol maleate.
    Joshi GV; Kevadiya BD; Patel HA; Bajaj HC; Jasra RV
    Int J Pharm; 2009 Jun; 374(1-2):53-7. PubMed ID: 19446759
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Layered bionanocomposites as carrier for procainamide.
    Kevadiya BD; Joshi GV; Bajaj HC
    Int J Pharm; 2010 Mar; 388(1-2):280-6. PubMed ID: 20074630
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effective cellular internalization, cell cycle arrest and improved pharmacokinetics of Tamoxifen by cholesterol based lipopolymeric nanoparticles.
    Mazumdar S; Italiya KS; Sharma S; Chitkara D; Mittal A
    Int J Pharm; 2018 May; 543(1-2):96-106. PubMed ID: 29578081
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Poly(d,l-lactide-co-glycolide)/montmorillonite nanoparticles for oral delivery of anticancer drugs.
    Dong Y; Feng SS
    Biomaterials; 2005 Oct; 26(30):6068-76. PubMed ID: 15894372
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long chain lipid based tamoxifen NLC. Part II: pharmacokinetic, biodistribution and in vitro anticancer efficacy studies.
    Shete H; Chatterjee S; De A; Patravale V
    Int J Pharm; 2013 Sep; 454(1):584-92. PubMed ID: 23535344
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Montmorillonite intercalated with glutathione for antioxidant delivery: synthesis, characterization, and bioavailability evaluation.
    Baek M; Choy JH; Choi SJ
    Int J Pharm; 2012 Apr; 425(1-2):29-34. PubMed ID: 22266539
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel paclitaxel-loaded poly(epsilon-caprolactone)/Poloxamer 188 blend nanoparticle overcoming multidrug resistance for cancer treatment.
    Zhang Y; Tang L; Sun L; Bao J; Song C; Huang L; Liu K; Tian Y; Tian G; Li Z; Sun H; Mei L
    Acta Biomater; 2010 Jun; 6(6):2045-52. PubMed ID: 19969111
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro biocompatibility and antimicrobial activity of poly(ε-caprolactone)/montmorillonite nanocomposites.
    Corrales T; Larraza I; Catalina F; Portolés T; Ramírez-Santillán C; Matesanz M; Abrusci C
    Biomacromolecules; 2012 Dec; 13(12):4247-56. PubMed ID: 23153018
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Poly-ε-caprolactone microspheres as a drug delivery system for cannabinoid administration: development, characterization and in vitro evaluation of their antitumoral efficacy.
    Hernán Pérez de la Ossa D; Ligresti A; Gil-Alegre ME; Aberturas MR; Molpeceres J; Di Marzo V; Torres Suárez AI
    J Control Release; 2012 Aug; 161(3):927-32. PubMed ID: 22580111
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Electrospun composite matrices of poly(ε-caprolactone)-montmorillonite made using tenside free Pickering emulsions.
    Samanta A; Takkar S; Kulshreshtha R; Nandan B; Srivastava RK
    Mater Sci Eng C Mater Biol Appl; 2016 Dec; 69():685-91. PubMed ID: 27612762
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tamoxifen-loaded thiolated alginate-albumin nanoparticles as antitumoral drug delivery systems.
    Martínez A; Benito-Miguel M; Iglesias I; Teijón JM; Blanco MD
    J Biomed Mater Res A; 2012 Jun; 100(6):1467-76. PubMed ID: 22396108
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Controlled release and antibacterial activity chlorhexidine acetate (CA) intercalated in montmorillonite.
    Meng N; Zhou NL; Zhang SQ; Shen J
    Int J Pharm; 2009 Dec; 382(1-2):45-9. PubMed ID: 19666092
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Montmorillonite-alginate nanocomposites as a drug delivery system: intercalation and in vitro release of vitamin B1 and vitamin B6.
    Kevadiya BD; Joshi GV; Patel HA; Ingole PG; Mody HM; Bajaj HC
    J Biomater Appl; 2010 Aug; 25(2):161-77. PubMed ID: 19737810
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biodegradable gelatin-ciprofloxacin-montmorillonite composite hydrogels for controlled drug release and wound dressing application.
    Kevadiya BD; Rajkumar S; Bajaj HC; Chettiar SS; Gosai K; Brahmbhatt H; Bhatt AS; Barvaliya YK; Dave GS; Kothari RK
    Colloids Surf B Biointerfaces; 2014 Oct; 122():175-183. PubMed ID: 25033437
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of the oral administration of polymeric nanoparticles on the efficacy and toxicity of tamoxifen.
    Jain AK; Swarnakar NK; Godugu C; Singh RP; Jain S
    Biomaterials; 2011 Jan; 32(2):503-15. PubMed ID: 20934747
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oridonin-loaded poly(epsilon-caprolactone)-poly(ethylene oxide)-poly(epsilon-caprolactone) copolymer nanoparticles: preparation, characterization, and antitumor activity on mice with transplanted hepatoma.
    Feng N; Wu P; Li Q; Mei Y; Shi S; Yu J; Xu J; Liu Y; Wang Y
    J Drug Target; 2008 Jul; 16(6):479-85. PubMed ID: 18604660
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.